A new antiviral compound designed and synthesized by researchers at the University of Wisconsin–Madison’s School of Pharmacy is highly effective in mice against two types of devastating encephalitis viruses that are harmful to humans.
A new antiviral compound designed and synthesized by researchers at the University of Wisconsin–Madison’s School of Pharmacy is highly effective in mice against two types of devastating encephalitis viruses that are harmful to humans.
Assistant Professor Quanyin Hu has developed a new method for targeting tumors with cancer drugs by exploiting the clotting propensity of blood platelets.
A team featuring School of Pharmacy alumni and faculty are recognized for their innovative telehealth antimicrobial stewardship program.
See the people, processes, and equipment fueling Professor Lingjun Li’s internationally recognized research program.
From COVID-19 to encephalitic alphaviruses, School of Pharmacy Associate Professor Jennifer Golden and collaborators are developing new antiviral treatments.
With funding from the American Diabetes Association, Professor Eva Vivian launches a study to help African American grandmothers initiate generational change in diabetes prevention.
Associate Professor Jason Kwan launches a new course to help undergraduates explore soil microbes and build hands-on skills in bioinformatics.
The winning paper by Professor Michelle Chui, alum Taylor Watterson (MS ’18, PhD ’22) and collaborators explores impactful changes to pharmacist and prescriber workflow.
An instructor at the School of Pharmacy for 26 years, Associate Professor Charles Lauhon receives the Chancellor’s Distinguished Teaching Award.
Through new NIH grant, School of Pharmacy Assistant Professor Jason Peters and collaborators are investigating bacteria viruses as a way to defeat antibiotic resistance.